Abstract
Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Clinical Protocols
-
Coagulase / metabolism
-
Diagnosis, Differential
-
Endophthalmitis / diagnosis
-
Endophthalmitis / drug therapy
-
Endophthalmitis / etiology*
-
Eye Infections, Bacterial / diagnosis
-
Eye Infections, Bacterial / drug therapy
-
Eye Infections, Bacterial / etiology*
-
Humans
-
Injections / adverse effects*
-
Injections / standards
-
Staphylococcus / enzymology
-
Staphylococcus / isolation & purification
-
Staphylococcus / physiology
-
Triamcinolone / adverse effects
-
Visual Acuity
-
Vitreous Body / microbiology
-
Vitreous Body / pathology
Substances
-
Anti-Bacterial Agents
-
Coagulase
-
Triamcinolone